Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis.

Deja R RoseAhmad Z MahadeenAlise K CarlsonSarah Marie PlanchonJennifer SedlakScott HusakRobert A Bermel Jeffrey A Cohen Brandon P Moss

Published in: Multiple sclerosis journal - experimental, translational and clinical (2021)

Patients treated with anti-CD20 agents and sphingosine 1-phosphate receptor modulators may still be at risk for COVID-19 despite vaccination. While still at risk for hospitalization, intubation and death from COVID-19 appear rare. Larger studies analyzing how this may differ in the setting of emerging variants are needed.

Keyphrases

sars cov
coronavirus disease
multiple sclerosis
respiratory syndrome coronavirus
small molecule
type diabetes
metabolic syndrome
gene expression
copy number
white matter
skeletal muscle
insulin resistance
case control